Improving state medical board policies: Influence of a model

Journal of Law, Medicine and Ethics

Volumn 31, Issue 1, 2003, Pages 119-129

  Gilson, Aaron M ^a   Joranson, David E ^a   Maurer, Martha A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; MIXED FUNCTION OXIDASE; NARCOTIC ANALGESIC AGENT; PHENYLACETATE 2 HYDROXYLASE; PHENYLACETATE 2-HYDROXYLASE;

ARTICLE; DRUG CONTROL; GOVERNMENT; HEALTH CARE AND PUBLIC HEALTH; HUMAN; LEGAL APPROACH; LEGAL ASPECT; LICENSING; MANAGEMENT; PAIN; PRACTICE GUIDELINE; STANDARD; UNITED STATES;

HEALTH CARE AND PUBLIC HEALTH; LEGAL APPROACH;

ANALGESICS, OPIOID; CYTOCHROME P-450 ENZYME SYSTEM; DRUG AND NARCOTIC CONTROL; HUMANS; LICENSURE, MEDICAL; MIXED FUNCTION OXYGENASES; PAIN; POLICY MAKING; PRACTICE GUIDELINES; STATE GOVERNMENT; UNITED STATES;

EID: 0042710006     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/j.1748-720X.2003.tb00062.x     Document Type: Review

References (39)

1. W Breitbart, M. Kaim, and B. Rosenfeld, "Clinicians' Perceptions of Barriers to Pain Management in AIDS," Journal of Pain and Symptom Management, 18, no. 3 (1999): 203-12;
2. W. Breitbart et al., "Patient-Related Barriers to Pain Management in Ambulatory AIDS Patients," Pain, 76 (1998): 9-16;
3. C.S. Cleeland, "Barriers to the Management of Cancer Pain," Oncology, suppl. (April 1987): 19-26;
4. R.A. Drayer, J. Henderson, and M. Reidenberg, "Barriers to Better Pain Control in Hospitalized Patients," Journal of Pain and Symptom Management, 17, no. 6 (1999): 434-40;
5. B.A. Ferrell, "Pain Evaluation and Management in the Nursing Home," Annals of Internal Medicine, 123, no. 9 (1995): 681-87;
6. C.S. Hill, Jr., "The Barriers to Adequate Pain Management with Opioid Analgesics," Seminars in Oncology, 20, no. 2, suppl. 1 (1993): 1-5;
7. D.E. Joranson, "Are Health-Care Reimbursement Policies a Barrier to Acute and Cancer Pain Management?, Journal of Pain and Symptom Management, 9, no. 4 (1994): 244-53, available at 〈http://www.medsch. wisc.edu/painpolicy/ publicat/94jpsma.htm〉;
8. D.E. Joranson, "Regulatory Influence on Pain Management: Real or Imagined?," Journal of Pharmaceutical Care in Pain and Symptom Control, 1, no. 1 (1993): 113-18, available at 〈http://www.medsch.wisc.edu/ painpolicy/publicat/93jpcpsc.htm〉;
9. F. Larue et al., "Oncologists and Primary Care Physicians' Attitudes Toward Pain Control and Morphine Prescribing in France," Cancer, 76, no. 11 (1995): 2375-82;
10. M. McCaffery, "Pain Control: Barriers to the Use of Available Information," Cancer, 70, no. 5 (1992): 1438-49;
11. B.A. Rich, "An Ethical Analysis of the Barriers to Effective Pain Management," Cambridge Quarterly of Healthcare Ethics, 9 (2000): 54-70;
12. S.W Tolle et al., "Family Reports of Barriers to Optimal Care of the Dying," Nursing Research, 49, no. 6 (2000): 310-17.
13. Cancer Pain Management Policy Review Group, American Cancer Society Position Statement on Regulatory Barriers to Quality Cancer Pain Management (Atlanta: American Cancer Society, 2001);
14. J.D. Haddox and G.M. Aronoff, "Commentary: The Potential for Unintended Consequences from Public Policy Shifts in the Treatment of Pain," Journal of Law, Medicine & Ethics, 26, no. 4 (1998): 350-52;
15. C.S. Hill, Jr., "The Negative Effect of Regulatory Agencies on Adequate Pain Control," Primary Care in Cancer, 11 (1989): 47-51;
16. C.S. Hill, Jr., "The Negative Influence of Licensing and Disciplinary Boards and Drug Enforcement Agencies on Pain Treatment with Opioid Analgesics," Journal of Pharmaceutical Care in Pain and Symptom Control, 1, no. 1 (1993): 43-62;
17. K.M. Foley and H. Gelband, eds., Institute of Medicine National Cancer Policy Board, Improving Palliative Care for Cancer (Washington, D.C.: National Academy Press, 2001), available at 〈http://www.nap.edu/catalog/10149. html〉.
18. Washington State Medical Disciplinary Board, Bulletin to Physicians: Chronic Pain (1987).
19. State of Washington Department of Health, Policy Statement (1989).
20. State of Washington Department of Health, Policy Statement to the Washington State Medical Disciplinary Board: Guidelines for Opiate Usage (1992): at 1.
21. State of Washington Department of Health, Guidelines for Management of Pain (1996), available at 〈http://www.medsch. wisc.edu/painpolicy/domestic/ wambguid.htm〉.
22. California Medical Board, "A Statement by the Medical Board," Action Report, 50 (1994): 4-5, available at 〈http://www. medsch.wisc.edu/painpolicy/domestic/cambstmt.htm〉;
23. California Medical Board, "Guideline for Prescribing Controlled Substances for Intractable Pain," Action Report, 51 (1994): 1, 8, available at 〈http://www.medsch.wisc.edu/painpolicy/domestic/cambguid. htm〉;
24. D.E. Joranson, "State Medical Board Guidelines for Treatment of Intractable Pain," American Pain Society Bulletin, 5, no. 3 (1995): 1-5, available at 〈http://www.medsch.wisc.edupain policy/publicat/95apssm. htm〉.
25. Federation of State Medical Boards of the United States, Model Guidelines for the Use of Controlled Substances for the Treatment of Pain (Euless, Texas: Federation of State Medical Boards of the United States, 1998), available through 〈http://www. fsmb.org〉.
26. Federation of State Medical Boards of the United States, Position of the Federation of State Medical Boards in Support of Adoption of Pain Management Guidelines (Euless, Texas: Federation of State Medical Boards of the United States, 2000), available at 〈http://www.medsch.wisc.edu/painpolicy/ domestic/FSMBwp.htm〉.
27. D.E. Joranson et al., 2001 Annual Review of State Pain Policies: A Question of Balance (Madison: Pain & Policy Studies Group, University of Wisconsin Comprehensive Cancer Center, 2002): at 2, available at 〈http://www.medsch.wisc.edu/ painpolicy/publicat/01annrev/contents. htm〉.
28. D.E. Joranson et al., Achieving Balance in Federal and State Pain Policy: A Guide to Evaluation (Madison: Pain & Policy Studies Group, University of Wisconsin Comprehensive Cancer Center, 2000): at 13-17, available at 〈http://www.medsch.wisc.edu/ painpolicy/eguide2000/index.html〉.
29. Idaho State Board of Medicine, "Prescribing Opioids for Chronic Pain," State Pamphlet (March 1995), available at 〈http:// www.medsch.wisc.edu/painpolicy/domestic/idmbguid.htm〉.
30. See Federation of State Medical Boards, supra note 8, at 2.
31. House of Delegates of the Federation of State Medical Boards (May 1998).
32. See Federation of State Medical Boards, supra note 9.
33. See California Medical Board, supra note 7.
34. See Joranson et al., supra note 11, at 18.
35. National Conference of Commissioners on Uniform State Laws, Uniform Controlled Substances Act (of 1990);
36. National Conference of Commissioners on Uniform State Laws, Uniform Controlled Substances Act (of 1994), available at 〈http://www. law.upenn.edu/bll/ulc/fnact99/1990s/ucsa94.pdf〉.
37. See Joranson et al., supra note 11.
38. D.E. Joranson, A.M. Gilson, and J.A. Nischik, "North Carolina, Pain Management and End-of-Life Care: Communicating the Policy," Federation Bulletin: Journal of Medical Licensure & Discipline, 88, no. 3 (2002): 116-19, available at 〈http:// www.medsch.wisc.edu/painpolicy/publicat/ 02fsmb/index.htm〉.
39. Maryland Board of Physician Quality Assurance: A Sense of Balance - Treating Chronic Pain, produced by Maryland Public Television: Special Projects Unit, 20 min. (1998), videocassette.